WEST PHARMACEUTICAL SERVICES INC Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
West Pharmaceutical Services Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • West Pharmaceutical Services Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $136M, a 15.7% decline year-over-year.
  • West Pharmaceutical Services Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $500M, a 10.7% decline year-over-year.
  • West Pharmaceutical Services Inc annual Net Income (Loss) Attributable to Parent for 2023 was $593M, a 1.28% increase from 2022.
  • West Pharmaceutical Services Inc annual Net Income (Loss) Attributable to Parent for 2022 was $586M, a 11.5% decline from 2021.
  • West Pharmaceutical Services Inc annual Net Income (Loss) Attributable to Parent for 2021 was $662M, a 91.2% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $593M +$7.5M +1.28% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $586M -$75.9M -11.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $662M +$316M +91.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $346M +$105M +43.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $242M +$34.8M +16.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-22
2018 $207M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2010 $65.3M Jan 1, 2010 Dec 31, 2010 10-K 2011-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.